Request an Appointment:
Online or Call 1-888-824-0200
South Loop

Make an Appointment at Our New Center for Advanced Care at South Loop

UChicago Medicine primary care physicians and specialists provide personalized care in a convenient location in Chicago's South Loop.

Duchossois Gift

$100 Million Gift Establishes Duchossois Family Institute to Develop 'New Science' Focused on Optimizing Health

Initiative combines our strengths in genetics, immunology, microbiome and big data to study how to harness body’s natural defenses

ASD and MFM patient Sana Khan with son and daughter

Sana's Birth Story

While pregnant with her son, Sana Khan was diagnosed with atrial septal defect (ASD) -- a hole in her heart. Learn how our team supported her through a safe pregnancy and delivery.

Clayton Harris

Moving Forward After Lymphoma

Clayton Harris was diagnosed with stage three lymphoma while his wife was pregnant with their first child. After receiving targeted treatment at UChicago Medicine, his cancer is in remission, and he is able to keep up with his two young sons.

Leapfrog Patient Safety Award

We're Bringing Our 'A' Game

Thank you to our dedicated physicians, nurses and staff for the high quality care they bring to our patients and their families every day. By placing the needs of patients "at the forefront," they've helped us achieve our 11th consecutive "A" safety rating from the Leapfrog Group.

Specialties and Departments

View all specialties and departments
Our Locations

Trauma Care on the South Side

Community Benefit Report

2015-2016 Community Benefit ReportThe University of Chicago Medicine (UCM) contributed $373 million in fiscal 2015 -- 18 percent more than the prior year -- to address the urgent health needs of the South Side and provide other assistance to the community.


» 2015-2016 Community Benefit Report
» Community initiatives
» Community news

 

UChicago Campaign

 

Science Life RSS

New research points to potential for more targeted treatments of deadly neuroblastoma tumors in children

Genetic variations appear to pre-dispose children to developing certain severe forms of neuroblastoma, according to new research by the University of Chicago Medicine. The findings lay the groundwork for developing more targeted treatments for particularly deadly variations of the cancer. 

 

Immunotherapy drug effective in triple-negative breast cancer

Rita Nanda, MD, presents results from the I-SPY 2 trial at the ASCO annual meeting showing that adding the checkpoint blocker pembrolizumab (Keytruda™) to standard therapy dramatically improved response rates for patients with invasive triple-negative breast cancer. 

Sign Up Today for MyChart















News

News | Science Life Blog

We've Hit Another Landmark

UChicago Medicine surgeons recently performed their 500th robotic cardiac surgery. 
» Learn more about our pioneering program in robotic and minimally invasive cardiac surgery


#